Style 10 (Orange) - Menu by Apycom.com

 
Home » Education

 

EDUCATION


7/2004 - 5/2006

M.S.
Master of Science in Clinical Research
Mount Sinai School of Medicine

7/2000 - 6/2004

Resident Physician
Department of Radiation Oncology
Mount Sinai School of Medicine, New York, New York

  • Chief Resident 2003 – 2004

7/1995 - 6/1999 M.D.
School of Medicine
State University of New York at Stony Brook, Stony Brook, New York

7/1993 - 6/1995 Post-baccalaureate Pre-med Program
School of General Studies
Columbia University, New York, New York

7/1989 - 6/1993

B.A., History
Columbia College
Columbia University, New York, New York

  • John Jacob Astor Scholar, 1989 - 1993

 

Connect
                                                   with Dr. Cesaretti

Schedule a Consultation
Request a Free Book
PSA Facts

RESEARCH EXPERIENCE

7/1993 - 6/1995

Research Assistant
Department of Pathology, College of Physicians & Surgeons
Columbia University, New York, New York

  • Lab focus on study of neuronal cytoskeleton and plaque-associated disease states.



GRANTS

Sponsor: Department of the Army, Prostate Cancer Research Program PC07201
Project entitled, ”Genome-Wide Association Study to Identify SNPs and CNPs Associated with Development of Radiation Injury in Prostate Cancer Patients Treated with Radiotherapy.”

Sponsor: National Institute of Health Loan Repayment Program
Project entitled, ”ATM Heterozygosity and the Development of Radiation-Induced Erectile Dysfunction and Urinary Morbidity Following Radiotherapy for Prostate Cancer.”

Sponsor: American Cancer Society
Project entitled, ”Genetic Predictors of Adverse Radiotherapy Response in African-Americans.”

Basic Science Travel Grant, Cesaretti JA
ASTRO Research Evaluation Committee
ASTRO's 46th Annual Meeting in Atlanta, GA from October 3-7, 2004

Physician Research Training Award, PCO31163, 2003,
Prostate Cancer Research Program.
Sponsor:  Department of Defense.
Project entitled, “ATM Heterozygosity and the Development of Radiation-Induced Erectile Dysfunction and Urinary Morbidity Following Radiotherapy for Prostate Cancer.”